about
The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancerMolecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseaseRole of Urinary Biomarkers in the Diagnosis of Adenoma and Colorectal Cancer: A Systematic Review and Meta-AnalysisThe diagnostics of colorectal cancer.Inter-individual methylation variability in differentially methylated regions between maternal whole blood and first trimester CVS.Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level.Novel multiplex MethyLight protocol for detection of DNA methylation in patient tissues and bodily fluids.Advances in epigenetic biomarker research in colorectal cancerGenomics and epigenomics of colorectal cancer.Histamine and histamine receptor regulation of gastrointestinal cancers.Diagnostic and prognostic epigenetic biomarkers in cancer.HMM-Fisher: identifying differential methylation using a hidden Markov model and Fisher's exact test.DNA methylation as an epigenetic biomarker in colorectal cancer.E-cadherin: A potential biomarker of colorectal cancer prognosis.Colorectal Cancer Blood-Based Biomarkers.Profiles of differentially expressed genes and overexpression of NEBL indicates a positive prognosis in patients with colorectal cancer.Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.CBD: a biomarker database for colorectal cancer.The Extraordinary Progress in Very Early Cancer Diagnosis and Personalized Therapy: The Role of Oncomarkers and Nanotechnology
P2860
Q21090644-6D51F393-B8BA-4554-ABDB-E894F1F42564Q24289344-B604585C-22F8-47B1-B850-874EAC14B5AFQ28067664-7A9236E3-EB87-4D0B-85AE-06476A3E8836Q33683652-82046DD0-A204-44FF-AAD5-021992DC2E69Q34568851-9412B1EC-AD3B-4766-8FCA-9C627875F357Q36535688-3CAA78CA-01B5-40BC-9814-1A4D0B42F99AQ37653469-936ACB0B-5C14-409E-9D60-ABDBDC3A63EEQ37708022-A311B358-2A07-4CDD-BF48-5EAE0339D34DQ38074617-883B0B40-5B08-4903-9941-553572139D59Q38196813-CE4AD5FA-6E18-49D9-8610-646540801843Q38610743-7BAA9D9D-CC80-4EA8-8208-5F8A60382A2AQ38795774-2046B127-DCB8-41C9-88C5-BAF9C32FE8BFQ39310872-320982A2-A0E2-4F0E-978E-D9199BEF307EQ39355560-0A391DD1-140E-4974-9569-3A5A3136CEA4Q46578913-21145CEA-D0B7-466D-BFC7-B0E08C7A2E1FQ49439117-3B97C460-EF6F-4131-8F23-277F438FC3ECQ54232902-F7F93440-D634-4D91-9466-2AEC54CDC87CQ55254366-374653A7-A914-4656-8040-E291C20616D0Q59129138-24A8CD32-7C3D-4A3A-B8B3-AB3901E69D95
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epigenetic biomarkers in colorectal cancer diagnostics.
@en
type
label
Epigenetic biomarkers in colorectal cancer diagnostics.
@en
prefLabel
Epigenetic biomarkers in colorectal cancer diagnostics.
@en
P2860
P356
P1476
Epigenetic biomarkers in colorectal cancer diagnostics.
@en
P2093
Bharati Bapat
James B Rawson
P2860
P304
P356
10.1586/ERM.12.39
P577
2012-06-01T00:00:00Z